Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1791-2021Class II

The Sarns TCM II (system) is a source of temperature-controlled water for blood heat exchangers used in an...

Terumo Cardiovascular Systems Corporation / initiated 2021-04-16 / Terminated / root cause: design

Terumo Cardiovascular Systems Corporation began a recall of The Sarns TCM II (system) is a source of temperature-controlled water for blood heat exchangers used in an extracorporeal circuit and for blankets to... on . FDA classified it as Class II and gives the reason as "Terumo CVS has been unable to validate a cleaning protocol to satisfy current regulatory concerns and expectations. As a result, an updated cleaning protocol will not be developed by Terumo CVS and it has been...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1791-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Terumo Cardiovascular Systems Corporation
Product
The Sarns TCM II (system) is a source of temperature-controlled water for blood heat exchangers used in an extracorporeal circuit and for blankets to externally heat or cool the patient. It also freezes water for an ice supply, monitors temperatures in the patient and extracorporeal circuit, and allows gradient rewarming relative to a venous blood temperature. The Sarns" TCM II also features a Cardioplegia System which will supply cooling water for cardioplegia. Device Name / Model Number: TCM II, with Cardioplegia, 110V/60Hz (P/N 164925) TCM II, without Cardioplegia, 110V/60Hz (P/N 164930) TCM II, with Cardioplegia, 220V/50Hz (P/N 164935) TCM II, without Cardioplegia, 220V/50Hz (P/N 164940) TCM (P/N 15747) Catalog Number: 4415, 164925, 164930, 164935, 15747
Product code
DWC Controller, Temperature, Cardiopulmonary Bypass
Reason for recall
Terumo CVS has been unable to validate a cleaning protocol to satisfy current regulatory concerns and expectations. As a result, an updated cleaning protocol will not be developed by Terumo CVS and it has been determined that the best course of action is for users to discontinue use of and dispose of HX2, TCM I and TCM II devices.
Root cause tag
design
FDA root cause
Device Design
Action
On 04/30/2021, Terumo issued an Urgent Medical Device Removal notice to customer via letter notifying users to discontinue the use of and dispose of HX2, TCM I and TCM II devices. Customers were instructed to confirm receipt of this communication by completing and returning the attached Customer Response Form as indicated on the form. For questions contact Terumo CVS Customer Service: 1-800-521-2818.
Quantity in commerce
995 devices
Distribution
Domestic: Foreign: Australia, Belgium, Canada, Chile, China, Colombia, Dominican Republic, England, France, Germany, Greece, Hong Kong, India, Indonesia, Iran, Israel, Italy, Japan, Korea, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Russia, Saudi Arabia, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UNITED ARAB EMIRATES (UAE), Vietnam
Product codes and lots
All lot numbers distributed from 05/02/1985 thru 06/10/2015

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1791-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1789-2021Class IITerminatedVoluntary: Firm initiated
Z-1790-2021Class IITerminatedVoluntary: Firm initiated
Z-1791-2021Class IITerminatedVoluntary: Firm initiated